MeiraGTx

Performance

About MeiraGTx

MeiraGTx is a clinical-stage genetic medicine company focused on developing potentially curative treatments for patients living with serious diseases. The company is advancing transformative technologies, including a riboswitch in-vivo delivery platform and next-generation vector optimization, with an end-to-end manufacturing ecosystem to enable scalable gene therapies. It operates globally and emphasizes precision control of gene expression to treat both rare and prevalent diseases across multiple programs and pipelines.